Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy
This study aims to systematically review randomized controlled trials on topical treatments for actinic keratosis field cancerization, following the PRISMA guidelines. Clinical recommendations were based on the Oxford Centre for Evidence-Based Medicine. We identified 20 original randomized controlled trials for topical cutaneous field therapy. 0.5% 5-Fluorouracil/salicylic acid and 0.5% 5-fluorouracil received a clinical recommendation grade of A, while diclofenac sodium received a clinical recommendation grade of B. Calcipotriol/5-fluorouracil, Imiquimod, sunscreen combination therapies, and tirbanibulin received a recommendation grade of C. This review provides a framework for clinicians when considering topical treatments for patients with field cancerization.PMID:38498070 | DOI:10.1007/s00403-024-02839-y
Source: Cell Research - Category: Cytology Authors: Paras Patel Jennifer Wang David Bitterman Jessica Mineroff Evan Austin Jared Jagdeo Source Type: research
More News: Cancer & Oncology | Carcinoma | Cytology | Dermatology | Diclofenac | Skin | Skin Cancer | Sodium | Squamous Cell Carcinoma | Study | Taclonex | Voltaren